Literature DB >> 4073181

Clinicopathologic report of successful cobalt 60 plaque therapy for choroidal melanoma.

G W Cleasby, B M Kutzscher.   

Abstract

A 66-year-old man had malignant melanoma of the choroid that enlarged during a two-year period while a retinal detachment developed. Treatment consisted of a cobalt 60 plaque placed to deliver a dose of 35,000 rads to the base and 9,000 rads to the apex of the tumor. Clinical response was excellent and complete regression occurred. The patient later died of an unrelated disease. Histopathologic study verified complete regression of the tumor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4073181     DOI: 10.1016/s0002-9394(14)73375-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Alterations of histone modifications by cobalt compounds.

Authors:  Qin Li; Qingdong Ke; Max Costa
Journal:  Carcinogenesis       Date:  2009-04-17       Impact factor: 4.944

2.  Is irradiation a justifiable treatment of choroidal melanoma? Analysis of published results.

Authors:  W A Manschot; R Van Strik
Journal:  Br J Ophthalmol       Date:  1987-05       Impact factor: 4.638

3.  Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma.

Authors:  E Messmer; N Bornfeld; M Foerster; H Schilling; A Wessing
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.